Inflammation related genes | Ctrl versus Ctrl D | Ctrl versus LPS | Ctrl versus OGD | OGD versus OGD D | LPS versus LPS D | LPS OGD versus LPS D OGD |
---|---|---|---|---|---|---|
Ptgs2, Prostaglandin-endoperoxide synthase 2 | 11.9 | 42.8 | Â | Â | Â | 0.4 |
Csf2rb1, Colony stimulating factor 2 receptor, beta 1 | 8.7 | Â | Â | Â | Â | Â |
Cd14, CD14 antigen | 8.4 | Â | Â | Â | 2.7 | Â |
Tgm2, Transglutaminase 2, C polypeptide | 7.2 | 7.4 | Â | Â | Â | 0.4 |
Bcl3, B-cell leukemia/lymphoma 3 | 6.9 | Â | Â | Â | Â | Â |
Socs3, Suppressor of cytokine signaling 3 | 5.8 | 11.7 | 2.6 | Â | Â | Â |
Cd86, CD86 antigen | 4.2 | Â | 2.2 | Â | Â | Â |
Sbno2, Strawberry notch homolog 2 (Drosophila) | 3.4 | Â | Â | Â | Â | Â |
Clcf1, Cardiotrophin-like cytokine factor 1 | 3.2 | Â | Â | Â | Â | Â |
Litaf, LPS-induced TN factor | 3.0 | 2.7 | Â | Â | Â | Â |
Edg3, Endothelial differentiation, sphingolipid G-protein-coupled receptor, 3 | 2.9 | Â | Â | Â | Â | Â |
Fcgr3, Fc receptor, IgG, low affinity III | 2.6 | Â | Â | Â | Â | Â |
Osmr, Oncostatin M receptor | 2.5 | 5.1 | Â | Â | Â | Â |
C5ar1, Complement component 5a receptor 1 | 2.4 | Â | Â | Â | Â | Â |
Il4ra, Interleukin 4 receptor, alpha | 2.4 | Â | Â | Â | 3.1 | Â |
Pde4d, Phosphodiesterase 4D, cAMP specific | 2.4 | Â | Â | Â | Â | Â |
Ccrl2, Chemokine (C–C motif) receptor-like 2 | 2.3 | 62.3 |  |  |  | 0.3 |
P2rx7, Purinergic receptor P2X, ligand-gated ion channel, 7 | 2.3 | Â | Â | Â | Â | Â |
Tnfrsf1b, Tumor necrosis factor receptor superfamily, member 1b | 2.3 | 5.0 | Â | Â | Â | 0.4 |
Cxcr7, Chemokine (C-X-C motif) receptor 7 | 2.2 | Â | Â | Â | 3.6 | Â |
Tgfbi, Transforming growth factor, beta induced | 2.1 | Â | Â | Â | Â | Â |
Fbxl8, F-box and leucine-rich repeat protein 8 | 0.5 | Â | Â | Â | Â | Â |
Iigp1, Interferon inducible GTPase 1 | 0.5 | 131.2 | Â | Â | 0.4 | 0.1 |
March1, Membrane-associated ring finger (C3HC4) 1 | 0.5 | Â | Â | Â | Â | Â |
Peli2, Pellino 2 | 0.5 | 0.4 | Â | Â | Â | Â |
Prrx1, Paired related homeobox 1 | 0.5 | Â | Â | Â | Â | Â |
Cmtm7, CKLF-like MARVEL transmembrane domain containing 7 | 0.4 | Â | Â | Â | Â | Â |
Ifit2, Interferon-induced protein with tetratricopeptide repeats 2 | 0.4 | 20.5 | Â | Â | 0.3 | 0.1 |
Pilra, Paired immunoglobin-like type 2 receptor alpha | 0.4 | Â | Â | Â | Â | 2.3 |
Selpl, Selectin, platelet (p-selectin) ligand | 0.4 | Â | Â | Â | Â | Â |
Ccl3, Chemokine (C–C motif) ligand 3 | 0.3 | 280.8 |  |  | 0.1 |  |
Cx3cr1, Chemokine (C-X3-C) receptor 1 | 0.3 | Â | Â | Â | 0.4 | Â |
F3, Coagulation factor III | 0.3 | Â | Â | Â | Â | Â |
Cxcl10, Chemokine (C-X-C motif) ligand 10 | 0.2 | 126.4 | Â | 2.5 | Â | 0.3 |
Tnf, Tumor necrosis factor | Â | 625.9 | 3.2 | Â | 0.1 | Â |
Ifit1, Interferon-induced protein with tetratricopeptide repeats 1 | Â | 143.8 | Â | Â | Â | 0.3 |
Mpa2Â l, Macrophage activation 2 like | Â | 120.1 | Â | Â | 0.5 | 0.3 |
Tnfaip3, Tumor necrosis factor, alpha-induced protein 3 | Â | 111.8 | Â | Â | 0.4 | 0.5 |
Tnfaip2, Tumor necrosis factor, alpha-induced protein 2 | Â | 102.3 | Â | Â | Â | 0.4 |
Igtp, Interferon gamma induced GTPase | Â | 96.0 | Â | Â | 0.4 | 0.2 |
Irf7, Interferon regulatory factor 7 | Â | 73.2 | Â | Â | Â | 0.2 |
Tyki, Thymidylate kinase family LPS-inducible member | Â | 72.0 | Â | Â | 0.4 | 0.1 |
Ptx3, Pentraxin related gene | Â | 60.0 | Â | Â | Â | Â |
Slfn5, Schlafen 5 | Â | 37.9 | Â | Â | Â | 0.4 |
Slfn2, Schlafen 2 | Â | 37.2 | Â | Â | Â | 0.5 |
Irf1, Interferon regulatory factor 1 | Â | 37.1 | Â | 2.3 | 0.4 | 0.5 |
Tap1, Transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | Â | 36.3 | Â | Â | Â | Â |
Tlr2, Toll-like receptor 2 | Â | 32.0 | Â | Â | Â | Â |
Ripk2, Receptor (TNFRSF)-interacting serine-threonine kinase 2 | Â | 23.9 | Â | Â | Â | Â |
Slfn9, Schlafen 9 | Â | 21.4 | Â | Â | Â | 0.3 |
Ly6a, Lymphocyte antigen 6 complex, locus A | Â | 16.4 | Â | Â | Â | 0.1 |
Ifi35, Interferon-induced protein 35 | Â | 16.1 | Â | Â | Â | 0.3 |
Ifi202b, Interferon activated gene 202B | Â | 14.1 | Â | Â | Â | 0.4 |
Tap2, Transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) | Â | 13.0 | Â | Â | Â | 0.4 |
Samhd1, SAM domain and HD domain, 1 | Â | 11.4 | Â | Â | Â | 0.4 |
Myd88, Myeloid differentiation primary response gene 88 | Â | 9.6 | Â | Â | Â | Â |
Ifi44, Interferon-induced protein 44 | Â | 8.8 | Â | Â | Â | 0.3 |
Plaur, Plasminogen activator, urokinase receptor | Â | 7.5 | Â | Â | Â | Â |
Tnip1, TNFAIP3 interacting protein 1 | Â | 7.5 | Â | Â | Â | Â |
Rnf125, Ring finger protein 125 | Â | 7.1 | Â | Â | Â | Â |
Ifi203, Interferon activated gene 203 | Â | 5.8 | Â | Â | Â | 0.3 |
H2-M3, Histocompatibility 2, M region locus 3 | Â | 5.7 | Â | Â | Â | 0.4 |
Nmi, N-myc (and STAT) interactor | Â | 5.0 | Â | Â | Â | 0.4 |
Irak2, Interleukin-1 receptor-associated kinase 2 | Â | 4.7 | Â | Â | Â | Â |
Tapbp, TAP binding protein | Â | 4.5 | Â | Â | Â | 0.4 |
Il17ra, Interleukin 17 receptor A | Â | 4.4 | Â | Â | Â | Â |
Tapbpl, TAP binding protein-like | Â | 4.2 | Â | Â | Â | Â |
Tcirg1, T-cell, immune regulator 1 | Â | 3.7 | Â | Â | Â | Â |
Plek, Pleckstrin | Â | 3.3 | Â | Â | Â | Â |
Irf2, Interferon regulatory factor 2 | Â | 3.2 | Â | Â | Â | Â |
Plau, Plasminogen activator, urokinase | Â | 3.1 | Â | Â | Â | Â |
Ifitm3, Interferon induced transmembrane protein 3 | Â | 2.9 | Â | Â | Â | 0.4 |
Ifrg15, Interferon alpha responsive gene | Â | 2.9 | Â | Â | Â | Â |
Tnfrsf14, Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | Â | 2.8 | Â | Â | Â | 0.4 |
Irf5, Interferon regulatory factor 5 | Â | 2.7 | Â | Â | Â | Â |
Tnfrsf12a, Tumor necrosis factor receptor superfamily, member 12a | Â | 2.7 | Â | Â | Â | Â |
C3, Complement component 3 | Â | 2.5 | Â | 2.2 | Â | Â |
Ifitm1, Interferon induced transmembrane protein 1 | Â | 2.5 | Â | Â | Â | Â |
Il18Â bp, Interleukin 18 binding protein | Â | 2.5 | Â | Â | Â | 0.4 |
Tcrb-V13, T-cell receptor beta, variable 13 | Â | 2.4 | Â | Â | Â | Â |
Traf2, Tnf receptor-associated factor 2 | Â | 2.4 | Â | Â | Â | Â |
Cxcl12, Chemokine (C-X-C motif) ligand 12 | Â | 2.3 | Â | Â | Â | Â |
Traf5, Tnf receptor-associated factor 5 | Â | 2.3 | Â | Â | Â | 0.5 |
Lcp1, Lymphocyte cytosolic protein 1 | Â | 2.2 | Â | Â | Â | Â |
Socs2, Suppressor of cytokine signaling 2 | Â | 2.2 | Â | Â | Â | Â |
Igsf10, Immunoglobulin superfamily, member 10 | Â | 2.1 | Â | Â | Â | Â |
Ptgir, Prostaglandin I receptor (IP) | Â | 2.1 | Â | Â | Â | Â |
Peli1, Pellino 1 | Â | 2.0 | Â | Â | Â | Â |
Tnfsf12, Tumor necrosis factor (ligand) superfamily, member 12 | Â | 0.5 | Â | Â | Â | Â |
Ptgs1, Prostaglandin-endoperoxide synthase 1 | Â | 0.4 | Â | Â | Â | Â |
Ptgds2, Prostaglandin D2 synthase 2, hematopoietic | Â | 0.3 | Â | Â | Â | Â |
Cxcr4, Chemokine (C-X-C motif) receptor 4 | Â | 0.2 | Â | Â | Â | Â |
Hmha1, Histocompatibility (minor) HA-1 | Â | 0.1 | Â | Â | Â | Â |
Ccl4, Chemokine (C–C motif) ligand 4 |  | 329.0 |  |  | 0.3 | 0.4 |
Trem2, Triggering receptor expressed on myeloid cells 2 | Â | 0.4 | Â | Â | Â | 2.5 |
Lgals3, Lectin, galactose binding, soluble 3 | Â | Â | 3.5 | Â | Â | 0.3 |
Aebp1 (gUuMeU):AE binding protein 1 | Â | Â | 2.2 | Â | Â | Â |
Trib1, Tribbles homolog 1 (Drosophila) | Â | Â | 2.2 | Â | Â | 0.5 |
Gbp6, Guanylate binding protein 6 | Â | Â | Â | 2.7 | Â | 0.4 |
Cd72, CD72 antigen | Â | Â | Â | 0.5 | Â | Â |
Inhba. Inhibin beta-A | Â | Â | Â | Â | 5.4 | Â |
Dusp14. Dual specificity phosphatase 14 | Â | Â | Â | Â | 2.6 | Â |
Itga1. Integrin alpha 1 | Â | Â | Â | Â | 2.6 | Â |
Csrp2. Cysteine and glycine-rich protein 2 | Â | Â | Â | Â | 2.5 | Â |
Csrp2. Cysteine and glycine-rich protein 2 | Â | Â | Â | Â | 2.4 | Â |
Ampd3. AMP deaminase 3 | Â | Â | Â | Â | 0.5 | Â |
C1r. Complement component 1. r subcomponent | Â | Â | Â | Â | 0.5 | 0.3 |
C3ar1. Complement component 3a receptor 1 | Â | Â | Â | Â | 0.5 | Â |
Cd274. CD274 antigen | Â | Â | Â | Â | 0.5 | 0.5 |
H2-D1. Histocompatibility 2. D region locus 1 | Â | Â | Â | Â | 0.5 | 0.1 |
Tgfb3. Transforming growth factor. beta 3 | Â | Â | Â | Â | 0.5 | Â |
Tgfbr2. Transforming growth factor. beta receptor II | Â | Â | Â | Â | 0.5 | Â |
Tlr4. Toll-like receptor 4 | Â | Â | Â | Â | 0.5 | Â |
Gvin1. GTPase. very large interferon inducible 1 | Â | Â | Â | Â | 0.4 | 0.3 |
Csf1. Colony stimulating factor 1 | Â | Â | Â | Â | 0.3 | 0.4 |
S100a4, S100 calcium binding protein A4 | Â | Â | Â | Â | Â | 2.1 |
Csf1r, Colony stimulating factor 1 receptor | Â | Â | Â | Â | Â | 2.0 |
Fcgr2b, Fc receptor, IgG, low affinity IIb | Â | Â | Â | Â | Â | 0.5 |
Scarf2, Scavenger receptor class F, member 2 | Â | Â | Â | Â | Â | 0.5 |
Stat2, Signal transducer and activator of transcription 2 | Â | Â | Â | Â | Â | 0.5 |
Gimap5, GTPase, IMAP family member 5 | Â | Â | Â | Â | Â | 0.4 |
H2-D4, Histocompatibility 2, D region locus 4 | Â | Â | Â | Â | Â | 0.4 |
H2-K1, Histocompatibility 2, K1, K region | Â | Â | Â | Â | Â | 0.4 |
Trafd1, TRAF type zinc finger domain containing 1 | Â | Â | Â | Â | Â | 0.4 |
Trex1, Three prime repair exonuclease 1 | Â | Â | Â | Â | Â | 0.4 |
B2Â m, Beta-2 microglobulin | Â | Â | Â | Â | Â | 0.3 |
Casp1, Caspase 1 | Â | Â | Â | Â | Â | 0.3 |
Fcgr1, Fc receptor, IgG, high affinity I | Â | Â | Â | Â | Â | 0.3 |
Irgm, Immunity-related GTPase family, M | Â | Â | Â | Â | Â | 0.3 |
Stat1, Signal transducer and activator of transcription 1 | Â | Â | Â | Â | Â | 0.3 |
Bst2, Bone marrow stromal cell antigen 2 | Â | Â | Â | Â | Â | 0.1 |
Ly6c, Lymphocyte antigen 6 complex, locus C | Â | Â | Â | Â | Â | 0.1 |
Ly6e, Lymphocyte antigen 6 complex, locus E | Â | Â | Â | Â | Â | 0.1 |